Delivery Order SPE2DB22D3004-SPE2DB25FPR64
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract is a delivery order with a firm fixed price of $1,524.36 and a completion date of June 7, 2023. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides medical supplies and pharmaceuticals to military and federal healthcare facilities. AmerisourceBergen holds a substantial...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Quillivant XR (25 mg/5 ml suspension, 120 ml). The contract has a ceiling value of $1,693.82 and is a firm fixed-price delivery order with a completion date of February 24, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication, and has a ceiling value of $1,577.04. The contract is a firm fixed-price Delivery Order with a completion date of January 22, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. The contract has a ceiling value of $4,528.40 and runs through February 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.38 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.16 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. The delivery order, valued at $6,340.16, has a firm fixed price and a performance period through July 18, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.90 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The $1,154.33 firm fixed-price delivery order has an ultimate completion date of October 24, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $3,534.72, is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside, indicating open...